Specialty diagnostics company Precipio (NSDQ:PRPO) announced today that it completed the non-cash acquisition of, among other transactions, the customer base of Poplar hematopathology division called OncoMetrix. The purchase involves no exchange of cash or equity, so it won’t provide a non-dilutive impact to shareholders, according to a news release. Precipio noted that successful implementation without disproportionate […]